BDBM50261053 1-(2-morpholinoethyl)-N-(naphthalen-1-yl)-2-oxo-1,2-dihydroquinazoline-3(4H)-carboxamide::CHEMBL494619

SMILES O=C(Nc1cccc2ccccc12)N1Cc2ccccc2N(CCN2CCOCC2)C1=O

InChI Key InChIKey=HJLBLBURTOHNHG-UHFFFAOYSA-N

Data  1 KI  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50261053   

TargetCannabinoid receptor 2(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50261053(1-(2-morpholinoethyl)-N-(naphthalen-1-yl)-2-oxo-1,...)
Affinity DataKi:  41nMAssay Description:Displacement of [3H]CP-55940 from human CB2 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50261053(1-(2-morpholinoethyl)-N-(naphthalen-1-yl)-2-oxo-1,...)
Affinity DataEC50:  22nMAssay Description:Agonist activity at human CB2 receptor assessed as inhibition of forskolin-stimulated cAMP productionMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed